Small Molecules
5 May 2014
Kadmon Corporation Presents Results of KD025 Preclinical and Clinical Studies at AAI Annual Meeting5 May 2014
Immune Pharmaceuticals Announces Phase 3 Development and Commercialization Strategy for AMIKET2 May 2014
Ruthigen Submits Investigational New Drug (IND) Application for Clinical Trial of RUT58-601 May 2014
GSK receives approval for Incruse™ Ellipta® (umeclidinium) in the US for the treatment of COPD1 May 2014
Theravance Announces Positive Results From a Phase 2 Study of TD-9855 in Patients With Fibromyalgia30 April 2014
Shire Announces Updates from Phase 3 Clinical Program for Lifitegrast in Adults With Dry Eye Disease30 April 2014
Cocrystal Pharma Updates on Influenza Program30 April 2014
New Data Reinforce Efficacy of TECFIDERA® (Dimethyl Fumarate) in MS Patients with High Disease ActivityNews Channels
Newsletter
La Merie Biologics
La Merie Publishing releases a weekly newsletter with a focus on biopharmaceutical research and development.
SubscribeNewsletter
New Product Alert
La Merie Publishing offers an e-mail notification service about the release of new products of La Merie Publishing. This New Product Release Alert also informs about the release of FREE reports produced by La Merie Publishing.
SubscribeFeatured reports